Synergy Chc earnings were $3.2M for the trailing 12 months ending Jun 30, 2025, with -45.7% growth year over year. The latest SNYR earnings report on Jun 30, 2025 announced Q2 2025 earnings of $1.5M, up 68.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNYR reported annual earnings of $2.1M, with -66.5% growth.
SNYR past earnings growth
How has SNYR's earnings growth performed historically?
Synergy Chc (NASDAQ: SNYR) reported Q2 2025 earnings per share (EPS) of $0.17, up 88.89% year over year. Total SNYR earnings for the quarter were $1.47 million. In the same quarter last year, Synergy Chc's earnings per share (EPS) was $0.09.
As of the last Synergy Chc earnings report, Synergy Chc is currently profitable. Synergy Chc's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $3.24 million, a 36.63% decrease year over year.
What was SNYR's earnings growth in the past year?
As of Synergy Chc's earnings date in Q3 2025, Synergy Chc's earnings has grown -45.71% year over year. This is 69.53 percentage points lower than the US Medical Distribution industry earnings growth rate of 23.81%. SNYR earnings in the past year totalled $3.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.